BioLineRx (BLRX) Net Income Attributable to Noncontrolling Interests (2026)
BioLineRx (BLRX) reported Income from Non-Controlling Interests of -$1.31 million for the quarter ended Jun 30, 2026.
Powered by 
Analysis
BioLineRx (BLRX) Net Income Attributable to Noncontrolling Interests (2026) Analysis & Trends
For the year ended Dec 31, 2025, BioLineRx posted Income from Non-Controlling Interests of -$851,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | - |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | - |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 10.00 Mn |
| 10 | BioLineRx | 6.74 Mn | -69.78 Mn | 235,000.00 | -1.31 Mn |
API Access
BioLineRx Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();